Company intelligence / Profile preview

New China Asset Management

Beijing, Beijing, China

Ownership: Private
Employees: ~500
Development stage: Other

Overview

New China Asset Management is a professional insurance asset management institution and a subsidiary of New China Life Insurance Company Ltd. (NCI). The company manages a diverse portfolio of assets, including fixed income, equity, and alternative investments, with a significant portion of its capital allocated to the healthcare, pharmaceutical, and life sciences sectors in China. While not a biotechnology company itself, it acts as a major institutional investor and financier for healthcare infrastructure and innovative medical enterprises within the Chinese market.

Industry: Investors

Beyond the preview

Go deeper on New China Asset Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New China Asset Management.

Explore the full profile